| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2006 |
Taxman DJ, Zhang J, Champagne C, Bergstralh DT, Iocca HA, Lich JD, Ting JP. Cutting edge: ASC mediates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -independent pathways. Journal of Immunology (Baltimore, Md. : 1950). 177: 4252-6. PMID 16982856 DOI: 10.4049/Jimmunol.177.7.4252 |
0.224 |
|
| 2008 |
Iocca HA, Plant SR, Wang Y, Runkel L, O'Connor BP, Lundsmith ET, Hahm K, van Deventer HW, Burkly LC, Ting JP. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. Journal of Neuroimmunology. 194: 97-106. PMID 18207576 DOI: 10.1016/J.Jneuroim.2007.12.003 |
0.208 |
|
| 2007 |
Plant SR, Iocca HA, Wang Y, Thrash JC, O'Connor BP, Arnett HA, Fu YX, Carson MJ, Ting JP. Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7429-37. PMID 17626203 DOI: 10.1523/Jneurosci.1307-07.2007 |
0.132 |
|
| 2010 |
Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, Chen VS, Gris D, Matsushima GK, Ting JP. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15811-20. PMID 21106820 DOI: 10.1523/Jneurosci.4088-10.2010 |
0.093 |
|
| 2006 |
Taxman DJ, Livingstone LR, Zhang J, Conti BJ, Iocca HA, Williams KL, Lich JD, Ting JP, Reed W. Criteria for effective design, construction, and gene knockdown by shRNA vectors. Bmc Biotechnology. 6: 7. PMID 16433925 DOI: 10.1186/1472-6750-6-7 |
0.09 |
|
| 2020 |
Ohsawa I, Honda D, Suzuki Y, Fukuda T, Kohga K, Morita E, Moriwaki S, Ishikawa O, Sasaki Y, Tago M, Chittick G, Cornpropst M, Murray SC, Dobo SM, Nagy E, ... ... Iocca H, et al. Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: a phase 3 randomized trial. Allergy. PMID 33247955 DOI: 10.1111/all.14670 |
0.08 |
|
| 2021 |
Farkas H, Stobiecki M, Peter J, Kinaciyan T, Maurer M, Aygören-Pürsün E, Kiani-Alikhan S, Wu A, Reshef A, Bygum A, Fain O, Hagin D, Huissoon A, Jeseňák M, Lindsay K, ... ... Iocca HA, et al. Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study. Clinical and Translational Allergy. 11: e12035. PMID 34161665 DOI: 10.1002/clt2.12035 |
0.078 |
|
| 2010 |
Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JP. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 974-81. PMID 20574004 DOI: 10.4049/Jimmunol.0904145 |
0.072 |
|
| 2008 |
O'Connor BP, Eun SY, Ye Z, Zozulya AL, Lich JD, Moore CB, Iocca HA, Roney KE, Holl EK, Wu QP, van Deventer HW, Fabry Z, Ting JP. Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses. Proceedings of the National Academy of Sciences of the United States of America. 105: 13015-20. PMID 18728195 DOI: 10.1073/Pnas.0803386105 |
0.063 |
|
| 2020 |
Zuraw B, Lumry WR, Johnston DT, Aygören-Pürsün E, Banerji A, Bernstein JA, Christiansen SC, Jacobs JS, Sitz KV, Gower RG, Gagnon R, Wedner HJ, Kinaciyan T, Hakl R, Hanzlíková J, ... ... Iocca HA, et al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial. The Journal of Allergy and Clinical Immunology. PMID 33098856 DOI: 10.1016/j.jaci.2020.10.015 |
0.053 |
|
| 2003 |
Iocca HA, Isom HC. Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. The American Journal of Pathology. 163: 465-76. PMID 12875968 DOI: 10.1016/S0002-9440(10)63676-0 |
0.048 |
|
| 2021 |
Wedner HJ, Aygören-Pürsün E, Bernstein J, Craig T, Gower R, Jacobs JS, Johnston DT, Lumry W, Zuraw BL, Best JM, Iocca HA, Murray SC, Desai B, Nagy E, Sheridan WP, et al. Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2). The Journal of Allergy and Clinical Immunology. in Practice. PMID 33866032 DOI: 10.1016/j.jaip.2021.03.057 |
0.047 |
|
| Hide low-probability matches. |